DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Consumer Retailing
Author Program NEWCreate Narrative
WBA logo

Walgreens Boots Alliance, Inc. Stock Price

NasdaqGS:WBA Community·US$10.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 188 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

WBA Share Price Performance

US$0
0.00 (0.00%)
​
US$11.93
Fair Value
US$0
0.00 (0.00%)
​
Price US$0
Thu, 5 Feb 26
Fair ValueUS$11.93
Share Pricen/a

WBA Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$11.93 Fairly Valued intrinsic discount

Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy

2users have liked this narrative
0users have commented on this narrative
91users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$10 19.8% overvalued intrinsic discount

Digital Shift Will Erode Retail And Pharmacy Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$14.1 15.0% undervalued intrinsic discount

Digital Health And An Aging Population Will Expand Retail Care

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
WBA logo
Walgreens Boots Alliance
Fairly Valued intrinsic discount

Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 7 May 2025
Read Narrative
WBA logo
Walgreens Boots Alliance
19.8% overvalued intrinsic discount

Digital Shift Will Erode Retail And Pharmacy Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Published 22 Jun 2025
Read Narrative
WBA logo
Walgreens Boots Alliance
15.0% undervalued intrinsic discount

Digital Health And An Aging Population Will Expand Retail Care

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 1 Jun 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
WBA logo

Digital Shift Will Erode Retail And Pharmacy Margins

Fair Value: US$10 19.8% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
WBA logo

Digital Health And An Aging Population Will Expand Retail Care

Fair Value: US$14.1 15.0% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
WBA logo

Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy

Fair Value: US$11.93 Fairly Valued intrinsic discount
91 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

1 Risk
3 Rewards
View Full Analysis

Walgreens Boots Alliance, Inc. Key Details

US$154.6b

Revenue

US$128.1b

Cost of Revenue

US$26.5b

Gross Profit

US$32.8b

Other Expenses

-US$6.3b

Earnings

Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
-7.28
17.13%
-4.07%
100.7%
View Full Analysis

About WBA

Founded
1909
Employees
252500
CEO
Timothy Wentworth
WebsiteView website
www.walgreensbootsalliance.com

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Recent WBA News & Updates

Recent updates

No updates

Walgreens Boots Alliance, Inc. Competitors

TGT logo

Target

Symbol: NYSE:TGT
Market cap: US$71.6b
SYY logo

Sysco

Symbol: NYSE:SYY
Market cap: US$39.1b
KR logo

Kroger

Symbol: NYSE:KR
Market cap: US$34.6b
DG logo

Dollar General

Symbol: NYSE:DG
Market cap: US$27.5b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide